The 9 best large, mid-sized, and small cities for recent college graduates
Many recent college graduates are looking for greener pastures, but not every city is well-suited for their needs.Read more...
NEWS Online - Business
Read More »
Diego Kazmierczak
23:19
Trump and Musk break up, a tariff truce teeters, and Disney layoffs: Business news roundup
President Donald Trump and Tesla (TSLA) CEO Elon Musk tore into one another on Thursday, as their close alliance collapsed
Johnathon Schildgen
23:19
Tesla stock plunges, layoffs surge, and housing cracks: Markets news roundup
The economic health of U.S. states varies widely, due to factors such as job growth, income levels, business development, and
Camellia Lanz
22:20
Single-dose CAR-T therapy potentially curative in multiple myeloma
A multi-institutional study led by the Icahn School of Medicine at Mount Sinai reports one-third of patients with relapsed or
TED
22:20
How can creativity help us heal? A doctor and a cartoonist answer | Amy Baxter and Navied Mahdavian
When medicine mixes with metaphor, what kind of healing transpires? In this unexpected meeting of minds, physician Amy Baxter shares
Anthony Howe
22:19
Marketing with Integrity: How Briget Niehues Is Redefining Growth Strategy in the Digital Age
Briget Niehues, a seasoned brand strategist and founder of Briget Brand Lab, is redefining what it means to build and
Blythe Drews
22:19
Potholes are costing Canadians billions. But there are some solutions
Potholes do more than slow us down, they're also a drag on the economy. Municipalities are spending millions more than
Joan Grumbles
19:20
Which Tx Combo Is Best for HER2+ Breast Cancer?
The combination of trastuzumab deruxtecan (Enhertu) with pertuzumab (Perjeta) as a first-line treatment for HER2-positive advanced metastatic breast cancer has
Georgianna Catt
19:20
Experimental MS Drug Nearly Eliminates Disease Activity
PHOENIX — Frexalimab, a second-generation anti-CD40 ligand monoclonal antibody provides extended tight control of multiple sclerosis (MS) whether measured by
Margarete Lupo
19:20
Canagliflozin CV Benefits Appear to Be Dose-Dependent
Cardiovascular benefits associated with the SGLT2 inhibitor drug canagliflozin appear to be dose-dependent, with benefits in some key clinical endpoints
